salvinorin a has been researched along with trk 820 in 6 studies
Studies (salvinorin a) | Trials (salvinorin a) | Recent Studies (post-2010) (salvinorin a) | Studies (trk 820) | Trials (trk 820) | Recent Studies (post-2010) (trk 820) |
---|---|---|---|---|---|
247 | 7 | 128 | 123 | 4 | 74 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 3 (50.00) | 29.6817 |
2010's | 1 (16.67) | 24.3611 |
2020's | 2 (33.33) | 2.80 |
Authors | Studies |
---|---|
BĂ©guin, C; Carlezon, WA; Cohen, BM; Duncan, KK; Liu-Chen, LY; Munro, TA; Wang, Y; Xu, W | 1 |
Cheng, J; McCorvy, JD; Tan, L; Yan, W | 1 |
Cowan, A; Holzgrabe, U; Huang, P; Inan, S; Lee, DY; Li, JG; Liu-Chen, LY; Siebert, D; Tang, K; Wang, Y | 1 |
Cowan, A; Inan, S; Lee, DY; Liu-Chen, LY | 1 |
Freeman, KB; Huskinson, SL; Naylor, JE; Prisinzano, TE; Townsend, EA; Zamarripa, CA | 1 |
Blough, BE; Brasfield, M; Follett, ME; Freeman, KB; Huskinson, SL; Platt, DM; Prisinzano, TE | 1 |
1 review(s) available for salvinorin a and trk 820
Article | Year |
---|---|
Biased Ligands of G Protein-Coupled Receptors (GPCRs): Structure-Functional Selectivity Relationships (SFSRs) and Therapeutic Potential.
Topics: Animals; Drug Discovery; Humans; Ligands; Receptors, G-Protein-Coupled; Signal Transduction; Structure-Activity Relationship | 2018 |
5 other study(ies) available for salvinorin a and trk 820
Article | Year |
---|---|
Standard protecting groups create potent and selective kappa opioids: salvinorin B alkoxymethyl ethers.
Topics: Alcohols; Diterpenes; Diterpenes, Clerodane; Ethers; Methylation; Molecular Structure; Receptors, Opioid, kappa; Structure-Activity Relationship | 2008 |
Comparison of pharmacological activities of three distinct kappa ligands (Salvinorin A, TRK-820 and 3FLB) on kappa opioid receptors in vitro and their antipruritic and antinociceptive activities in vivo.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics; Animals; Antipruritics; Aza Compounds; Binding, Competitive; Diterpenes; Diterpenes, Clerodane; Down-Regulation; Endocytosis; Female; Guanosine 5'-O-(3-Thiotriphosphate); Humans; Hydrocarbons, Fluorinated; Male; Mice; Morphinans; Nociceptin Receptor; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu; Spiro Compounds; Sulfur Radioisotopes | 2005 |
Comparison of the diuretic effects of chemically diverse kappa opioid agonists in rats: nalfurafine, U50,488H, and salvinorin A.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Animals; Diterpenes, Clerodane; Diuresis; Diuretics; Dose-Response Relationship, Drug; Male; Morphinans; Rats; Rats, Sprague-Dawley; Receptors, Opioid, kappa; Spiro Compounds; Structure-Activity Relationship; Time Factors | 2009 |
Kappa opioid agonists reduce oxycodone self-administration in male rhesus monkeys.
Topics: Analgesics, Opioid; Animals; Behavior, Addictive; Cocaine; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Macaca mulatta; Male; Morphinans; Naltrexone; Narcotic Antagonists; Oxycodone; Receptors, Opioid, kappa; Reinforcement, Psychology; Self Administration; Spiro Compounds | 2020 |
Quantification of observable behaviors induced by typical and atypical kappa-opioid receptor agonists in male rhesus monkeys.
Topics: 3,4-Dichloro-N-methyl-N-(2-(1-pyrrolidinyl)-cyclohexyl)-benzeneacetamide, (trans)-Isomer; Analgesics, Opioid; Animals; Behavior, Animal; Diterpenes, Clerodane; Dose-Response Relationship, Drug; Macaca mulatta; Male; Morphinans; Motor Activity; Oxycodone; Receptors, Opioid, kappa; Spiro Compounds | 2020 |